Prescription opioids may play role in some fatal two-car crashes

(Reuters Health) – In fatal two-car crashes, drivers deemed to have caused the wreck were almost twice as likely as those who were not at fault to test positive for opioids, a U.S. study finds.

The most common error leading to fatal crashes, whether or not opioids were involved, was drivers veering out of their lanes, according to the results published in JAMA Network Open.

“This shows that the ongoing national opioid epidemic has spilled over to our national highway system with deadly consequences,” said study coauthor Dr. Gouhua Li, founding director of the Center for Injury Epidemiology and Prevention at the Mailman School of Public Health of Columbia University in New York City. “Drivers who caused the crashes were about twice as likely to have taken prescription opiates as the non-initiators of the crashes.”

To take a closer look at the impact of drugs on fatal vehicle crashes, the researchers turned to the Fatality Analysis Reporting System (FARS) which is compiled and maintained by the National Center for Statistics at the U.S. National Highway Traffic Safety Administration.

FARS keeps detailed data on all motor vehicle crashes that occur on U.S. public roads and result in at least one fatality. The researchers analyzed data from 18,321 fatal two-car crashes. The most common driver error causing those crashes, “failure to keep in lane,” occurred in 7,535 instances, the researchers found.

Drivers who were found to have caused the crashes were more likely than those who were not at fault to test positive for prescription opioids (918 versus 549) and alcohol (5,258 versus 1,815). As a sign that the problem has been growing, the proportion of crash initiators with prescription opioids in their system increased from 2 percent in 1993 to 7.1 percent in 2016.

Among the 1,467 drivers testing positive for prescription opioids, 32 percent were positive for hydrocodone, 27 percent for morphine, 19 percent for oxycodone, 14 percent for methadone and 9 percent for other prescription opioids.

Because of its design, the study can only show an association rather than proof that opioids cause crashes, said Dr. Andrew Stolbach, a medical toxicologist and emergency medicine physician at the Johns Hopkins Hospital in Baltimore, Maryland.

Moreover, it does not suggest that people who are taking opioids for chronic pain are having accidents because of the drugs, said Stolbach, also an associate professor of emergency medicine at the Johns Hopkins University School of Medicine. “You can have psychomotor and cognitive impairment in people who are not used to taking them,” he explained.

“But there is scientific literature, using driving simulators, for example, that shows that when a person builds up tolerance many of the psychomotor and cognitive effects that would affect driving are not detected. And that suggests that people on a chronic and stable opioid prescription can drive safely,” Stolbach said.

The same is not true for people taking opioids for an acute injury such as a burn or a broken limb, he noted.

Dr. Ajay Wasan, who wasn’t involved in the study, questioned its focus on any use of prescription opioids among drivers involved in crashes, describing it as “very misleading, since this is really abuse, not use.”

Given that studies have shown that people taking prescription opioids chronically are not impaired when driving, these kinds of accidents, especially those where people drifted out of their lanes, are most likely due to opioid abuse, said Wasan, who is vice chair for pain medicine in the anesthesiology department at the University of Pittsburgh and president elect of the American Academy of Pain Medicine.

Moreover, Wasan expects that the number of accidents involving people taking prescription opioids will turn out to have gone down in more recent years because of the decline in the number of prescriptions written for opioids.

“This sensationalizes an issue when there is a need for better science and clarity,” Wasan said.

SOURCE: bit.ly/2GNDszH JAMA Network Open, online February 15, 2019.

Source

more recommended stories

  • Senator Gillibrand wants insurance to pay for fertility treatments

    WASHINGTON (Reuters) – U.S. Democratic presidential.

  • Hundreds rally at U.S. Supreme Court, calling state abortion bans as step backward

    WASHINGTON (Reuters) – Abortion-rights campaigners, including.

  • French court says doctors must resume life support for paralyzed patient

    STRASBOURG, France (Reuters) – A French.

  • Missouri follows Alabama by passing restrictive abortion bill

    (Reuters) – Missouri lawmakers passed a.

  • Too much screen time tied to school problems even in little kids

    (Reuters Health) – Kindergarteners who get.

  • Smokers have higher risk for multiple strokes

    (Reuters Health) – Smokers who have.

  • Missouri assembly passes restrictive abortion bill, days after Alabama

    (Reuters) – The lower house of.

  • Missouri Senate passes bill to ban abortions after eight weeks

    (Reuters) – Missouri’s Senate passed a.

  • Alabama governor signs strictest U.S. abortion ban into law

    (Reuters) – Alabama’s governor signed a.

  • Alabama Senate bans nearly all abortions, including rape cases

    (Reuters) – Alabama’s state Senate passed.

  • Israel regulator warns of medical cannabis bubble, eyes Australia pact

    JERUSALEM (Reuters) – Medical cannabis could.

  • U.S. measles outbreak grows with 75 new cases, mostly in New York

    (Reuters) – U.S. health authorities recorded.

  • Teva Pharm CFO says company did not conspire to fix prices

    FILE PHOTO: The logo of Teva.

  • U.S. states accuse Teva, other drugmakers, of price-fixing: lawsuit

    WASHINGTON (Reuters) – U.S. states filed.

  • Exclusive: Philip Morris suspends social media campaign after Reuters exposes young ‘influencers’

    (Reuters) – Cigarette maker Philip Morris.

  • Hong Kong reports African swine fever case

    HONG KONG (Reuters) – Hong Kong.

  • Alabama Senate delays vote on strict anti-abortion bill

    (Reuters) – Alabama’s state Senate on.

  • Denver votes to become first U.S. city to decriminalize ‘magic mushrooms’

    Psilocybin or “magic mushrooms” are seen.

  • AstraZeneca-Daiichi Sankyo breast cancer drug shows promise

    The company logo for pharmaceutical company.

  • Denver to vote on decriminalizing ‘magic mushrooms’

    FILE PHOTO: Boxes containing magic mushrooms.

  • Trans teens face higher sexual assault risk when schools restrict bathrooms

    (Reuters Health) – Transgender adolescents may.

  • U.S. doctors use medical records to fight measles outbreak

    CHICAGO (Reuters) – U.S. doctors are.

  • UK’s Vectura wins patent infringement case against GlaxoSmithKline in U.S

    (Reuters) – British drugmaker Vectura Group.

  • Tyson Foods recalls almost 12 million pounds of chicken strips over contamination fears

    (Reuters) – Tyson Foods Inc significantly.

  • Monstrous rumors stoke hostility to Pakistan’s anti-polio drive

    PESHAWAR, Pakistan (Reuters) – His bearded.

  • U.S. health agency finalizes conscience and religious freedom rule

    WASHINGTON (Reuters) – The U.S. Department.

  • Medication use drops when local drugstores close

    (Reuters Health) – People are less.

  • EPA says popular weed killer glyphosate is not a carcinogen

    CHICAGO (Reuters) – The U.S. Environmental.

  • Novartis’s Sandoz strikes deal for biosimilar of Herceptin

    FILE PHOTO: Swiss drugmaker Novartis’ logo.

  • U.S. measles outbreak triggers quarantine at two Los Angeles universities

    LOS ANGELES (Reuters) – A nationwide.

  • U.S. measles outbreak raises questions about immunity in adults

    (Reuters) – Adults in the United.

  • FDA approves expanded label for Regeneron/Sanofi’s cholesterol drug

    (Reuters) – The U.S. Food and.